Amrita Pati

机构：Amgen (United States)

发表论文 387 篇 · 总被引 15355 次 · h-index 48

代表论文

• Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study (2023 · Journal of Clinical Oncology · 被引 338)
• 1,003 reference genomes of bacterial and archaeal isolates expand coverage of the tree of life (2017 · Nature Biotechnology · 被引 273)
• Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer (2025 · Nature Medicine · 被引 44)
• Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization (2019 · Archives of Pathology & Laboratory Medicine · 被引 38)
• Comparing polysaccharide decomposition between the type strains Gramella echinicola KMM 6050T (DSM 19838T) and Gramella portivictoriae UST040801-001T (DSM 23547T), and emended description of Gramella echinicola Nedashkovskaya et al. 2005 emend. Shahina et al. 2014 and Gramella portivictoriae Lau et al. 2005 (2016 · Standards in Genomic Sciences · 被引 16)
• Erratum to: The standard operating procedure of the DOE-JGI Microbial Genome Annotation Pipeline (MGAP v.4) (2016 · Standards in Genomic Sciences · 被引 15)